Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subpectoral Bupivacaine for Pain Management in Adolescent Reduction Mammaplasty
NCT05898087Phase 4Completed
- Sponsor
- Connecticut Children's Medical Center
- Start
- Apr 2022
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine hydrochloride 0.75% injection in postoperative pain, sponsored by Connecticut Children's Medical Center. Started Apr 2022; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05898087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05898087.